How to Scale Up Your Clinical Trials

A doctor and patient in a clinical trial consultation.
Pharmaceutical companies are under pressure to bring new drugs to market quickly. This urgency is driven by the needs of patients, requirements from authorities, and investors. Clinical trials are a crucial part of this process, but they can be delayed by manual processes.
Clinical Trials Supply Chain

Very often, clinical trials involve many manual tasks that can be time-consuming and error-prone, causing delays. Several barriers to success occur during clinical trials, where 90% of drug candidates fail at some point during testing. When this happens, scientists are forced to start the process all over again. This can make clinical trials take a very long time, sometimes more than a decade. It also prevents larger studies from being designed in a time- and cost-effective way.

By automating manual tasks and integrating systems, it can improve every stage of trial design, from patient-screening to temperature-monitoring, making each step more efficient and accurate. Automation provides an excellent solution by streamlining processes, reducing mistakes, and offering real-time data.

Key Benefits of Automation

  1. Efficiency and Accuracy: Automated systems reduce the need for manual tasks, minimizing human error and freeing up time for clinical staff. This can include automating data entry, patient monitoring, and temperature tracking. Real-time data allows for quick corrective actions and ensures that trials stay on schedule.
  2. Compliance and Quality Management: Automated systems help ensure compliance by maintaining accurate records and generating necessary documentation for audits and regulatory submissions. This simplifies quality management and helps maintain high standards.
  3. Improved Data Management: Clinical trial regulations require extensive data transparency and long-term data retention. Automated systems facilitate the collection, storage, and analysis of all types of trial data, creating a comprehensive and accessible database. This is crucial for long-term compliance, as sponsors and investigators often must archive clinical trial data for more than 25 years.

Why Automated Temperature Monitoring in Clinical Trials is Crucial

Automated temperature monitoring is a game-changing technology to enable faster clinical trials processes and can contribute to shortening study timelines by reducing time kits spend in quarantine. It increases efficiency, enhance compliance with strict regulatory standards, improves data management, and ultimately accelerates the delivery of new drugs to market.

As the pharmaceutical industry continues to innovate and adopt new trial designs, such as Decentralized Clinical Trials and Direct-to-Patient, the importance of reliable temperature monitoring systems cannot be overstated.

By integrating automated temperature monitoring into clinical trial processes, pharmaceutical companies can overcome significant barriers to trial efficiency and effectiveness. This not only speeds up the development and approval of new therapies but also ensures that these therapies reach patients in the safest and most effective way possible. In an industry where time is crucial and lives are at stake, embracing automation in temperature monitoring is essential.

Temperature Monitoring in Decentralized Clinical Trials

Decentralized Clinical Trials (DCTs) allow trial activities to take place outside traditional clinical settings, such as in participants' homes. While DCTs offer greater flexibility and convenience for patients, they also introduce complexities in the supply chain, particularly regarding temperature control.

Automated temperature monitoring is essential in DCTs to ensure that drugs are stored and transported under optimal conditions. By using seamless and integrated systems, sponsors can maintain the integrity of the trial regardless of location, ensuring that participants receive drugs in their intended state. This is particularly important for maintaining GxP compliance and ensuring that data collected from DCTs is reliable and valid.

     

The Impact of Automated Temperature Monitoring in Clinical Trials

     

Faster Trials: By eliminating the need for manual temperature checks, automated systems speed up the trial process and increase the dispense rate. This is especially important in urgent situations, such as during pandemics or for drugs that address critical health issues.

Cost Savings: While the initial investment in automated systems may be higher, the long-term savings are significant. Reduced labor costs, fewer delays, and a lower risk of temperature-related drug spoilage result in substantial financial benefits.

Enhanced Patient Safety: Keeping drugs within their optimal temperature ranges is crucial for patient safety. Automated systems provide reliable monitoring, reducing the risk of administering compromised drugs and ultimately increasing the sponsor credibility.

Simplified Reporting: Automated temperature monitoring systems make it easier to generate compliance reports, helping to meet regulatory requirements and prepare for audits. This not only saves time but also ensures the accuracy and completeness of the data.

TSS Clinical Module >

     

Sources:

'Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use'
'US FDA Clinical Trials and Human Subject Protection'

'Streamlining clinical trials for patients and clinicians through digital'

'Modern technologies are doubling the odds of scientists making life-changing medical discoveries'

You may also be interested in

Promotional banner for the GCSG European Knowledge Forum in Athens, announcing a vendor showcase hosted by TSS.

GCSG Athens 2023 Vendor Showcase Hosted by TSS

In light of the recent EMA and FDA guidelines, this session will discuss what role temperature monitoring may play in decentralized (DCT) and direct-to-patient (DTP) studies.
Read moreDownload Whitepaper
Profile photo of Gustaf Rasin, new Chief Operations Officer at TSS.

TSS Welcomes Gustaf Rasin as New Chief Operations Officer

TSS, a prominent provider of temperature monitoring solutions, is delighted to announce the appointment of Gustaf Rasin as its new Chief Operations Officer (COO). Gustaf Rasin will play a vital role in refining the company's operational workflows and fostering its growth and environmental sustainability vision.
Read moreDownload Whitepaper

The year in review: TSS’s most-read blog articles of 2021

As 2021 draws to a close, we’ve rounded up the most-read stories we’ve published on our blog in the past 12 months – featuring automation, new technologies, data, clinical supply, and pharma logistics.
Read moreDownload Whitepaper

You may also be interested in

Can You Rely on the Results from Your Clinical Trials?

The success of a clinical trial depends on the reliability of its data. Many investigational drugs are sensitive to temperature, and any temperature deviation can affect their quality and, in the worst case, patient safety. Automated and integrated temperature monitoring solutions help secure data quality, support compliance, and speed up the delivery of new medicines to patients.
Read more

Extending TempMonitor BLE to Ultra-Low Temperatures

Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.